Neurocrine Biosciences
NBIX
#1591
Rank
NZ$22.56 B
Marketcap
NZ$226.27
Share price
-1.38%
Change (1 day)
-16.04%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend yield history for this company